Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
peanut sublingual immunotherapy tablet
- Development stage
- Phase 2
- Lead developer
- ALK Abelló
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Sublingual
01
Overview
The peanut sublingual immunotherapy (SLIT) tablet is an investigational biologic product developed by ALK for the treatment of peanut allergy. Utilizing ALK's proprietary sublingual tablet technology platform, the drug contains a standardized extract of peanut protein allergens. It is designed to induce clinical desensitization and long-term immune tolerance by gradually exposing the patient's immune system to increasing doses of peanut allergens through daily sublingual administration. This process aims to modulate the allergic immune response, potentially reducing the risk and severity of allergic reactions, including anaphylaxis, upon accidental exposure to peanuts. The product is currently being evaluated in the Phase I/II ALLIANCE clinical trial across pediatric and adult populations.
- Other names
- Peanut SLIT-tabletPeanut allergen extract sublingual tablet
02
Targets
Ara h 2
Beyond the preview
Go deeper on peanut sublingual immunotherapy tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on peanut sublingual immunotherapy tablet.